THOMAS ALBERICO, MD
Hematology & Oncology Physician · NORFOLK, VA
Individual Active NPI 1922001064
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,326 | 380,434 | $33,490,027 | $9,339,501 | $7,467,498 |
| 2023 | 1,247 | 373,040 | $29,144,838 | $7,597,947 | $6,069,186 |
| 2022 | 1,578 | 381,312 | $30,760,670 | $8,346,975 | $6,669,136 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 46,800 | $3 | $2 |
| J9299 | Injection, nivolumab, 1 mg | 32,800 | $31 | $25 |
| J9271 | Injection, pembrolizumab, 1 mg | 31,800 | $56 | $44 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 24,660 | $50 | $40 |
| J1453 | Injection, fosaprepitant, 1 mg | 20,550 | $0 | $0 |
| J9025 | Injection, azacitidine, 1 mg | 14,700 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 14,396 | $0 | $0 |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 13,100 | $14 | $11 |
| J0185 | Injection, aprepitant, 1 mg | 8,060 | $2 | $1 |
| Q5110 | Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 7,200 | $0 | $0 |
| J9041 | Injection, bortezomib, 0.1 mg | 6,510 | $2 | $1 |
| J0897 | Injection, denosumab, 1 mg | 6,300 | $25 | $20 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 0101032895 | VA |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Virginia
- NPI 1477540177
- NPI 1255397477
- NPI 1770802373
- NPI 1669868774
- NPI 1578875217
- NPI 1821454018
- NPI 1467445999
- NPI 1215225552
See all Hematology & Oncology Physician providers in Virginia →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.